Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Prostate Cancer

  Free Subscription


Articles published in J Magn Reson Imaging

Retrieve available abstracts of 32 articles:
HTML format
Text format



Single Articles


    June 2017
  1. HEIDKAMP J, Hoogenboom M, Kovacs IE, Veltien A, et al
    Ex vivo MRI evaluation of prostate cancer: Localization and margin status prediction of prostate cancer in fresh radical prostatectomy specimens.
    J Magn Reson Imaging. 2017 Jun 5. doi: 10.1002/jmri.25785.
    PubMed     Text format     Abstract available


    April 2017
  2. KRISHNA S, Lim CS, McInnes MD, Flood TA, et al
    Evaluation of MRI for diagnosis of extraprostatic extension in prostate cancer.
    J Magn Reson Imaging. 2017 Apr 7. doi: 10.1002/jmri.25729.
    PubMed     Text format     Abstract available


    February 2017
  3. LIN YC, Lin G, Hong JH, Lin YP, et al
    Diffusion radiomics analysis of intratumoral heterogeneity in a murine prostate cancer model following radiotherapy: Pixelwise correlation with histology.
    J Magn Reson Imaging. 2017 Feb 8. doi: 10.1002/jmri.25583.
    PubMed     Text format     Abstract available


  4. JAMBOR I, Bostrom PJ, Taimen P, Syvanen K, et al
    Novel biparametric MRI and targeted biopsy improves risk stratification in men with a clinical suspicion of prostate cancer (IMPROD Trial).
    J Magn Reson Imaging. 2017 Feb 6. doi: 10.1002/jmri.25641.
    PubMed     Text format     Abstract available


  5. WASEDA Y, Yoshida S, Takahara T, Kwee TC, et al
    Utility of computed diffusion-weighted MRI for predicting aggressiveness of prostate cancer.
    J Magn Reson Imaging. 2017 Feb 2. doi: 10.1002/jmri.25593.
    PubMed     Text format     Abstract available


  6. WOLF MB, Edler C, Tichy D, Rothke MC, et al
    Diffusion-weighted MRI treatment monitoring of primary hypofractionated proton and carbon ion prostate cancer irradiation using raster scan technique.
    J Magn Reson Imaging. 2017 Feb 2. doi: 10.1002/jmri.25635.
    PubMed     Text format     Abstract available


    December 2016
  7. GINSBURG SB, Algohary A, Pahwa S, Gulani V, et al
    Radiomic features for prostate cancer detection on MRI differ between the transition and peripheral zones: Preliminary findings from a multi-institutional study.
    J Magn Reson Imaging. 2016 Dec 19. doi: 10.1002/jmri.25562.
    PubMed     Text format     Abstract available


    October 2016
  8. KIM W, Kim CK, Park JJ, Kim M, et al
    Evaluation of extracapsular extension in prostate cancer using qualitative and quantitative multiparametric MRI.
    J Magn Reson Imaging. 2016 Oct 17. doi: 10.1002/jmri.25515.
    PubMed     Text format     Abstract available


  9. SCHIEDA N, Lim CS, Idris M, Lim RS, et al
    MRI assessment of pathological stage and surgical margins in anterior prostate cancer (APC) using subjective and quantitative analysis.
    J Magn Reson Imaging. 2016 Oct 11. doi: 10.1002/jmri.25510.
    PubMed     Text format     Abstract available


  10. GORDON LG, James R, Tuffaha HW, Lowe A, et al
    Cost-effectiveness analysis of multiparametric MRI with increased active surveillance for low-risk prostate cancer in Australia.
    J Magn Reson Imaging. 2016 Oct 11. doi: 10.1002/jmri.25504.
    PubMed     Text format     Abstract available


    September 2016
  11. ZHANG YD, Wu CJ, Bao ML, Li H, et al
    MR-based prognostic nomogram for prostate cancer after radical prostatectomy.
    J Magn Reson Imaging. 2016 Sep 21. doi: 10.1002/jmri.25441.
    PubMed     Text format     Abstract available


  12. REAM JM, Doshi AM, Dunst D, Parikh N, et al
    Dynamic contrast-enhanced MRI of the prostate: An intraindividual assessment of the effect of temporal resolution on qualitative detection and quantitative analysis of histopathologically proven prostate cancer.
    J Magn Reson Imaging. 2016 Sep 20. doi: 10.1002/jmri.25451.
    PubMed     Text format     Abstract available


  13. LEE MS, Cho JY, Kim SY, Cheon GJ, et al
    Diagnostic value of integrated PET/MRI for detection and localization of prostate cancer: Comparative study of multiparametric MRI and PET/CT.
    J Magn Reson Imaging. 2016 Sep 1. doi: 10.1002/jmri.25384.
    PubMed     Text format     Abstract available


    July 2016
  14. YUAN Q, Costa DN, Senegas J, Xi Y, et al
    Quantitative diffusion-weighted imaging and dynamic contrast-enhanced characterization of the index lesion with multiparametric MRI in prostate cancer patients.
    J Magn Reson Imaging. 2016 Jul 21. doi: 10.1002/jmri.25391.
    PubMed     Text format     Abstract available


  15. SALAMI SS, Ben-Levi E, Yaskiv O, Turkbey B, et al
    Risk stratification of prostate cancer utilizing apparent diffusion coefficient value and lesion volume on multiparametric MRI.
    J Magn Reson Imaging. 2016 Jul 13. doi: 10.1002/jmri.25363.
    PubMed     Text format     Abstract available


  16. GREER MD, Brown AM, Shih JH, Summers RM, et al
    Accuracy and agreement of PIRADSv2 for prostate cancer mpMRI: A multireader study.
    J Magn Reson Imaging. 2016 Jul 8. doi: 10.1002/jmri.25372.
    PubMed     Text format     Abstract available


    June 2016
  17. GNEP K, Fargeas A, Gutierrez-Carvajal RE, Commandeur F, et al
    Haralick textural features on T2 -weighted MRI are associated with biochemical recurrence following radiotherapy for peripheral zone prostate cancer.
    J Magn Reson Imaging. 2016 Jun 27. doi: 10.1002/jmri.25335.
    PubMed     Text format     Abstract available


    April 2016
  18. BALDISSEROTTO M, Neto EJ, Carvalhal G, de Toledo AF, et al
    Validation of PI-RADS v.2 for prostate cancer diagnosis with MRI at 3T using an external phased-array coil.
    J Magn Reson Imaging. 2016 Apr 26. doi: 10.1002/jmri.25284.
    PubMed     Text format     Abstract available


  19. ROSENKRANTZ AB, Shanbhogue AK, Wang A, Kong MX, et al
    Length of capsular contact for diagnosing extraprostatic extension on prostate MRI: Assessment at an optimal threshold.
    J Magn Reson Imaging. 2016;43:990-7.
    PubMed     Text format     Abstract available


    March 2016
  20. LIM C, Flood TA, Hakim SW, Shabana WM, et al
    Evaluation of apparent diffusion coefficient and MR volumetry as independent associative factors for extra-prostatic extension (EPE) in prostatic carcinoma.
    J Magn Reson Imaging. 2016;43:726-36.
    PubMed     Text format     Abstract available


    February 2016
  21. DE PERROT T, Scheffler M, Boto J, Delattre BM, et al
    Diffusion in prostate cancer detection on a 3T scanner: How many b-values are needed?
    J Magn Reson Imaging. 2016 Feb 23. doi: 10.1002/jmri.25206.
    PubMed     Text format     Abstract available


  22. TAMADA T, Sone T, Kanomata N, Miyaji Y, et al
    Value of preoperative 3T multiparametric MRI for surgical margin status in patients with prostate cancer.
    J Magn Reson Imaging. 2016 Feb 13. doi: 10.1002/jmri.25185.
    PubMed     Text format     Abstract available


  23. ROSENKRANTZ AB, Meng X, Ream JM, Babb JS, et al
    Likert score 3 prostate lesions: Association between whole-lesion ADC metrics and pathologic findings at MRI/ultrasound fusion targeted biopsy.
    J Magn Reson Imaging. 2016;43:325-32.
    PubMed     Text format     Abstract available


    November 2015
  24. REISCHAUER C, Koh DM, Froehlich JM, Patzwahl R, et al
    Pilot study on the detection of antiandrogen resistance using serial diffusion-weighted imaging of bone metastases in prostate cancer.
    J Magn Reson Imaging. 2015 Nov 20. doi: 10.1002/jmri.25102.
    PubMed     Text format     Abstract available


    July 2015
  25. TILAK G, Tuncali K, Song SE, Tokuda J, et al
    3T MR-guided in-bore transperineal prostate biopsy: A comparison of robotic and manual needle-guidance templates.
    J Magn Reson Imaging. 2015;42:63-71.
    PubMed     Text format     Abstract available


  26. CEPEK J, Lindner U, Ghai S, Louis AS, et al
    Mechatronic system for in-bore MRI-guided insertion of needles to the prostate: An in vivo needle guidance accuracy study.
    J Magn Reson Imaging. 2015;42:48-55.
    PubMed     Text format     Abstract available


    June 2015
  27. COFFEY N, Schieda N, Cron G, Gulavita P, et al
    Multi-parametric (mp) MRI of prostatic ductal adenocarcinoma.
    J Magn Reson Imaging. 2015;41:1639-45.
    PubMed     Text format     Abstract available


    April 2015
  28. ZHANG Z, Yuan Q, Zhou H, Zhao D, et al
    Assessment of tumor response to oxygen challenge using quantitative diffusion MRI in an animal model.
    J Magn Reson Imaging. 2015 Apr 10. doi: 10.1002/jmri.24914.
    PubMed     Text format     Abstract available


    June 2014
  29. JAMBOR I, Kahkonen E, Taimen P, Merisaari H, et al
    Prebiopsy multiparametric 3T prostate MRI in patients with elevated PSA, normal digital rectal examination, and no previous biopsy.
    J Magn Reson Imaging. 2014 Jun 23. doi: 10.1002/jmri.24682.
    PubMed     Text format     Abstract available


  30. GINSBURG SB, Viswanath SE, Bloch BN, Rofsky NM, et al
    Novel PCA-VIP scheme for ranking MRI protocols and identifying computer-extracted MRI measurements associated with central gland and peripheral zone prostate tumors.
    J Magn Reson Imaging. 2014 Jun 18. doi: 10.1002/jmri.24676.
    PubMed     Text format     Abstract available


    May 2014
  31. ROSENKRANTZ AB, Geppert C, Grimm R, Block TK, et al
    Dynamic contrast-enhanced MRI of the prostate with high spatiotemporal resolution using compressed sensing, parallel imaging, and continuous golden-angle radial sampling: Preliminary experience.
    J Magn Reson Imaging. 2014 May 16. doi: 10.1002/jmri.24661.
    PubMed     Text format     Abstract available


    April 2014
  32. KALAVAGUNTA C, Zhou X, Schmechel SC, Metzger GJ, et al
    Registration of in vivo prostate MRI and pseudo-whole mount histology using Local Affine Transformations guided by Internal Structures (LATIS).
    J Magn Reson Imaging. 2014 Apr 4. doi: 10.1002/jmri.24629.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: